Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 12 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 11090344

    Adenovirus and immunomodulator combination therapy

    The Board of Regents of the University of Texas System · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  2. US 11091555

    Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy

    Five Prime Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  3. US 11083737

    Methods of administering deflazacort therapy

    PTC THERAPEUTICS, INC. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  4. US 11083752

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

  5. US 11078295

    Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases

    VACCINEX, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  6. US 11065332

    Combination therapy of immunotoxin and checkpoint inhibitor

    The Government of The United States as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  7. US 11059906

    Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma

    Takeda Pharmaceutical Company Limited · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  8. US 11059880

    Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  9. US 11052116

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  10. US 11052115

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  11. US 11045443

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  12. SG 11202104918P

    THERAPY FOR TREATING CANCER WITH AN INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION OF A RECOMBINANT MVA ENCODING 4-1BBL (CD137L) AND/OR CD40L

    BAVARIAN NORDIC AS [DK] · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  13. US 11045558

    RPGR gene therapy for retinitis pigmentosa

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  14. US 11040070

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  15. US 11033623

    Magnetic stem cell therapy for lesions

    GREINER BIO-ONE NORTH AMERICA, INC. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  16. US 11034739

    Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases

    The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  17. US 11033635

    Antibody-STING agonist conjugates and their use in immunotherapy

    The Board of Regents of the University of Texas System · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  18. US 11020409

    Broad antiviral therapy with membrane modifying oxysterols

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  19. US 11021545

    Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  20. US 11013770

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted

  21. US 11013803

    Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 25, 2021 · Expires May 20, 2041

    granted

  22. US 11007226

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted

  23. US 11007217

    Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy

    United Kingdom Research and Innovation · Granted May 18, 2021 · Expires May 13, 2041

    granted

  24. US 11001641

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 11, 2021 · Expires May 6, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.